MNS News vFinal DR 27/6/08 12:25 Page 9
NEWSDESK
9
Improvement for diabetics
DEBIOTECH and STMicroelectronics can be worn as a nearly invisible patch administered several times a day. With
introduced evaluation prototypes of a on the skin. CSII, the patient is connected to a
unique miniaturised insulin delivery Microfluidic technology also provides programmable pump including a storage
pump. The tiny device can be mounted on better control of the administered insulin reservoir, from which insulin is infused
a disposable skin patch to provide doses, more closely mimicking the into the tissue under the skin throughout
continuous insulin infusion, enabling natural secretion of insulin from the the day according to specific needs as
substantial advancements in the pancreas, while detecting potential programmed by the patient.
availability, treatment efficiency and the malfunctions of the pump to further The insulin nanopump, developed by
quality of life of diabetes patients. The protect patients. Debiotech and industrialised by ST,
nanopump, which relies on microfluidic As a disposable device, manufactured represents the most advanced use of
MEMS (Micro Electro Mechanical using high volume semiconductor microfluidic MEMS technology in
System) technology, has successfully processing technologies, the MEMS diabetes treatment.
passed initial testing stages and is now based nanopump is also much more “The success of the initial prototype
ready to enter volume manufacturing. affordable, allowing the patient or the tests has moved the revolutionary insulin
The highly miniaturised disposable health system to avoid the substantial up nanopump a step closer to market
insulin pump combines Debiotech’s from investment typically associated with availability,” said Benedetto Vigna,
expertise in insulin delivery systems with current pump solutions. Group Vice President and General
ST’s strengths in manufacturing high Insulin pump therapy, or Continuous Manager of ST’s MEMS and Healthcare,
volume silicon based microfluidic devices. Subcutaneous Insulin Infusion (CSII), is RF Transceivers and Sensors Division.
The nanopump is less than one fourth the an increasingly attractive alternative to “Working with our key partner
size of existing insulin pump devices and individual insulin injections that must be Debiotech, we are readying a tiny piece
of silicon that can make a huge
difference to millions of diabetes patients
around the world.”
Cash boost for
“This important milestone in the
industrial production of the insulin
Swedish power
nanopump is a key achievement toward
the successful launch of a new drug
transistor maker
delivery device with a level of safety for
the patient,” said Dr. Frederic Neftel,
President and CEO of Debiotech.
TranSiC AB, developer of power
transistors in the wide bandgap material
silicon carbide announced that it has
ANSYS to buy
raised SEK 24 million ($ 4 million, EUR
2.6 million) venture capital in a second
Ansoft
financing round with Industrifonden ,
Volvo Technology Transfer and Midroc
New Technology. ANSYS and Ansoft Corporation
“This investment will enable us to go announced that the Securities and
from prototyping and sampling power Exchange Commission has concluded
components to our customers to qualify its review of the Registration
components and our manufacturing Statement on Form S-4 in connection
processes. We are also planning to use with ANSYS’ acquisition of Ansoft.
part of the funding to support more sales development of a suitable package An amended Form S-4 was filed and
and marketing activities”, according to technology. became effective on 20 June 2008. A
Bo Hammarlund, VP of Sales & Development and device fabrication is special meeting of the Ansoft
Marketing and one of the founders. performed in the Electrum Laboratory in stockholders to approve the
TranSiC develops and manufactures Kista, Sweden, where a four inch line transaction has been set for 23 July
power bipolar junction transistors (BJTs) suited to SiC device technology, is 2008.
in silicon carbide, under the trademark available. TranSiC has also access to As previously announced, ANSYS
BitSiC. Today 20 Amperes and 6 excellent device characterisation facilities and Ansoft have entered into a
Amperes components are available for and to testing in applications through co- definitive merger agreement in which
1200 Volts in various packages and as operation with pilot customers. ANSYS will acquire Ansoft for a
integrated power modules. Key “TranSiC is the only manufacturer purchase price of approximately $832
advantages of the BitSiC are higher world wide which ships silicon carbide million in a mix of cash and ANSYS
current gains and faster switching BJT power transistors for the hybrid common stock based on the 10 day
compared to silicon power bipolar electrical vehicle industry. TranSiC is way trailing average closing price of
junction transistors. In addition, the ahead of competitors which is very ANSYS common stock prior to
BitSiC chip operates well at promising for the future says Stefan announcement of the transaction on
temperatures exceeding 250
0
C, and this Jakelius Investment manager at 31 March 2008.
opens up for new applications after Industrifonden.
July 2008
www.micronanosystems.info
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86 |
Page 87 |
Page 88